专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

41. 发明授权

US09728726B2 Organic electroluminescent element, material for organic electroluminescent element and light emitting device, display device, and illumination device, each employing organic electroluminescent element 有权
公开(公告)号：US09728726B2
公开(公告)日：2017-08-08
申请号：US14350745
申请日：2012-11-01
申请人： UDC Ireland Limited
发明人： Koji Takaku , Yasunori Yonekuta , Masaru Kinoshita , Wataru Sotoyama , Toshihiro Ise , Kuniyuki Kaminaga , Heijiro Hirayama
IPC分类号： H01L51/00 , H01L51/50 , C07D213/74 , C07C255/58 , C07D219/14 , C07C211/56 , C07C211/61 , C07D239/42 , C07D471/06 , C07D487/06 , C07D493/06 , C07D209/86 , C07B59/00 , C07F7/08 , C09K11/06 , H05B33/10 , C09B57/00 , C09B1/00
CPC分类号： H01L51/0056 , C07B59/001 , C07B2200/05 , C07C211/56 , C07C211/61 , C07C255/58 , C07C2603/54 , C07D209/86 , C07D213/74 , C07D219/14 , C07D239/42 , C07D471/06 , C07D487/06 , C07D493/06 , C07F7/0807 , C09B1/00 , C09B57/00 , C09B57/008 , C09K11/06 , C09K2211/1007 , C09K2211/1011 , C09K2211/1014 , C09K2211/1029 , C09K2211/1044 , C09K2211/1088 , C09K2211/1096 , H01L51/0052 , H01L51/006 , H01L51/0072 , H01L51/0074 , H01L51/5012 , H05B33/10
摘要： This application relates in part to an organic electroluminescent element including a substrate, a pair of electrodes including an anode and a cathode, disposed on the substrate, and an organic layer(s) including a light emitting layer, in which the organic layer(s) contains a compound represented by the following formula (1), in which R1 to R8 are each hydrogen or a substituent, at least one of R1 to R4 and at least one of R5 to R8 are each a substituent represented by the formula (2); R9 to R12, Z1 to Z4, Ar1, Ar2, and L1 are as defined herein.

42. 发明授权

US09718826B2 Imidazopyrazinone derivatives 有权
公开(公告)号：US09718826B2
公开(公告)日：2017-08-01
申请号：US15107211
申请日：2014-12-03
申请人： Merck Patent GmbH
发明人： Hans-Peter Buchstaller , Dieter Dorsch
IPC分类号： C07D487/04 , A61K31/4985 , C07D487/06
CPC分类号： C07D487/04 , A61K31/4985 , C07D487/06
摘要： Compounds of the formula I in which R1 and R2 have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.

43. 发明授权

US09708296B2 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD 有权
公开(公告)号：US09708296B2
公开(公告)日：2017-07-18
申请号：US15150976
申请日：2016-05-10
申请人： Takeda Pharmaceutical Company Limited
发明人： Jason W. Brown , Melinda Davis , Anthony Ivetac , Benjamin Jones , Andre A. Kiryanov , Jon Kuehler , Marion Lanier , Joanne Miura , Sean Murphy , Xiaolun Wang
IPC分类号： C07D401/14 , C07D405/14 , C07D413/14 , A61K31/443 , A61K31/4439 , A61K31/444 , A61K31/5377 , A61K31/496 , A61K31/551 , C07D401/04 , C07D491/107 , C07D417/14 , C07D471/08 , C07D487/06 , C07D487/10 , C07D491/10 , A61K31/4545 , A61K31/4985 , A61K31/5513 , C07D487/04
CPC分类号： C07D401/14 , A61K31/444 , A61K31/4545 , A61K31/496 , A61K31/4985 , A61K31/5377 , A61K31/551 , A61K31/5513 , C07D401/04 , C07D405/14 , C07D413/14 , C07D417/14 , C07D471/08 , C07D487/04 , C07D487/06 , C07D487/10 , C07D491/10 , C07D491/107
摘要： The present invention provides compounds of the formula: which are useful as inhibitors of PHD, pharmaceutical compositions thereof, methods for treatment of conditions associated with HIF, processes for making the compounds and intermediates thereof.

44. 发明申请

US20170107234A1 TRICYCLIC HETEROCYCLE DERIVATIVES HAVING HIV REPLICATION INHIBITORY EFFECT 有权
公开(公告)号：US20170107234A1
公开(公告)日：2017-04-20
申请号：US15311757
申请日：2015-05-15
申请人： Shionogi & Co., Ltd.
发明人： Takashi KAWASUJI , Daisuke TANIYAMA , Shuichi SUGIYAMA , Yoshinori TAMURA
IPC分类号： C07D513/06 , C07D471/06 , C07D471/16 , C07D487/06
CPC分类号： C07D513/06 , A61K31/519 , A61K31/5513 , A61K31/554 , C07D471/06 , C07D471/16 , C07D487/06 , Y02P20/55
摘要： The present invention provides the following compound having anti-HIV activity of formula: wherein, A1 is C, CR1A or N; A2 is C, CR2A, or N; A3 is CR3A, CR3AR3B, N, NR3C, O, S, SO, or SO2; A4 is CR4A, CR4AR4B, N, NR4C, O, S, SO, or SO2; A5 is C, CR5A, or N; T1 ring is substituted or unsubstituted monocyclic carbocycle or substituted or unsubstituted monocyclic heterocycle; R1 is halogen, cyano, nitro or —X1—R11; R2 is substituted or unsubstituted alkyl and the like; n is 1 or 2; R3 is hydrogen, substituted or unsubstituted aromatic carbocyclyl; R4 is hydrogen or a carboxy protecting group; the other symbols are as specified in the description.

45. 发明授权

US09551029B2 Methods and kits using extended rhodamine dyes 有权
标题翻译：使用延长罗丹明染料的方法和试剂盒
公开(公告)号：US09551029B2
公开(公告)日：2017-01-24
申请号：US14927908
申请日：2015-10-30
申请人： APPLIED BIOSYSTEMS, LLC
发明人： Joe Y. L. Lam , Scott C. Benson , Steven M. Menchen
IPC分类号： C12Q1/68 , C07H21/00 , C07D209/60 , C07D221/08 , C07D221/10 , C07D471/06 , C07D487/06 , C07D491/14 , C07H19/04 , C09B11/24
CPC分类号： C12Q1/6869 , C07D209/60 , C07D221/08 , C07D221/10 , C07D471/06 , C07D487/06 , C07D491/14 , C07H19/04 , C07H21/00 , C09B11/24 , C12Q1/68 , C12Q1/6816 , Y10S435/968 , Y10S435/975 , Y10S436/80 , Y10T436/143333
摘要： Extended rhodamine compounds exhibiting favorable fluorescence characteristics having the structure are disclosed. In addition, novel intermediates for synthesis of these dyes are disclosed, such intermediates having the structure In addition, methods of making and using the dyes as fluorescent labels are disclosed.
摘要翻译：此外，公开了制造和使用染料作为荧光标记的方法。

46. 发明申请

US20160260908A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES 审中-公开
标题翻译：有机电致发光材料和器件
公开(公告)号：US20160260908A1
公开(公告)日：2016-09-08
申请号：US15040553
申请日：2016-02-10
申请人： UNIVERSAL DISPLAY CORPORATION
发明人： Lichang ZENG , Alexey Borisovich DYATKIN , Walter YEAGER , Zeinab ELSHENAWY , Chuanjun XIA
IPC分类号： H01L51/00 , C09K11/06 , C07D487/06 , C09K11/02
摘要： Organic compounds consisting of indolo[321-jk]carbazole and carbazole are disclosed. The compounds are useful as host materials in OLEDs and can improve OLED performance.
摘要翻译：公开了由吲哚并[3,2-jk]咔唑和咔唑组成的有机化合物。这些化合物可用作OLED中的主体材料，并且可以改善OLED性能。

47. 发明授权

US09346804B2 Tricyclic oxazolidinone antibiotic compounds 有权
标题翻译：三环恶唑烷酮抗生素化合物
公开(公告)号：US09346804B2
公开(公告)日：2016-05-24
申请号：US14096419
申请日：2013-12-04
申请人： Christian Hubschwerlen , Daniel Ritz , Georg Rueedi , Jean-Philippe Surivet , Cornelia Zumbrunn-Acklin
发明人： Christian Hubschwerlen , Daniel Ritz , Georg Rueedi , Jean-Philippe Surivet , Cornelia Zumbrunn-Acklin
IPC分类号： A61K31/54 , A61K31/535 , C07D471/06 , C07D471/16 , C07D487/06 , C07D519/00
CPC分类号： C07D471/06 , C07D471/16 , C07D487/06 , C07D519/00
摘要： The present invention relates to antibacterial compounds of formula (I) wherein “----” is a bond or is absent, V is CH, CR6 or N; R0 is H or, if “----” is a bond, may also be alkoxy; R1 is cyano, alkyl, or ethynyl; U is CH or N when “----” is a bond, or, if “----” is absent, U is CH2, NH or NH9; R2 is H, alkylcarbonyl or CH2—R3; R3 is H, alkyl or hydroxyalkyl; R4 is H or, if n is not 0 and R5 is H, may also be OH; R5 is H, alkyl, hydroxyalkyl, aminoalkyl, alkoxyalkyl, carboxy or alkoxycarbonyl; R6 is hydroxyalkyl, carboxy, alkoxycarbonyl or —(CH2)q—NR7R8, q being 1, 2 or 3 and each of R7 and R8 independently being H or alkyl or R7 and R8 forming with the N atom bearing them a ring; R9 is alkyl or hydroxyalkyl; A is —(CH2)p—, —CH2CH2CH(OH)— or —COCH2CH(OH)—; G is substituted phenyl or G1 or G2, wherein Q is O or S and X is CH or N; and Y1, Y2 and Y3 may each be CH or N; and n is 0 when A is —CH2CH2CH(OH)— or —COCH2CH(OH)—, and n is 0, 1 or 2 when A is —(CH2)p—, p being 1, 2, 3 or 4, with the proviso that the sum of n and p is then 2, 3 or 4; and to salts of such compounds.
摘要翻译：本发明涉及式（I）的抗菌化合物，其中“----”是键或不存在，V是CH，CR 6或N; R 0是H，或者如果“----”是键，也可以是烷氧基; R1是氰基，烷基或乙炔基; 当“----”是键时，U是CH或N，或者如果不存在“----”，则U是CH 2，NH或NH 9; R2是H，烷基羰基或CH2-R3; R3是H，烷基或羟烷基; R4是H或如果n不为0且R5是H，也可以是OH; R5是H，烷基，羟基烷基，氨基烷基，烷氧基烷基，羧基或烷氧基羰基; R6是羟基烷基，羧基，烷氧基羰基或 - （CH2）q-NR7R8，q是1,2或3，R7和R8各自独立地是H或烷基或R7和R8与带有它们的N原子形成环; R9是烷基或羟烷基; A是 - （CH 2）p - ， - CH 2 CH 2 CH（OH） - 或-COCH 2 CH（OH） - ; G是取代的苯基或G1或G2，其中Q是O或S，X是CH或N; Y1，Y2和Y3各自为CH或N; 当A为-CH 2 CH 2 CH（OH） - 或-COCH 2 CH（OH） - 时，n为0，当A为 - （CH 2）p - ，p为1,2,3或4时，n为0,1或2，条件是n和p之和为2,3或4; 和这些化合物的盐。

48. 发明申请

US20160111660A1 DELAYED FLUORESCENCE COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME 有权
标题翻译：延迟荧光化合物和有机发光二极管和使用其的显示器件
公开(公告)号：US20160111660A1
公开(公告)日：2016-04-21
申请号：US14885785
申请日：2015-10-16
申请人： LG Display Co., Ltd.
发明人： Joong-Hwan YANG , Kyung-Jin YOON , Hyo-Jin NOH , Dae-Wi YOON , In-Ae SHIN , Jun-Yun KIM
IPC分类号： H01L51/00 , C09K11/06 , C07D487/06 , H01L51/50 , H01L51/52
CPC分类号： H01L51/0072 , C07D487/04 , C07D487/06 , C09K11/06 , C09K2211/1014 , C09K2211/1029 , C09K2211/1092 , H01L51/0059 , H01L51/0061 , H01L51/0074 , H01L51/5004 , H01L51/5012 , H01L51/5056 , H01L51/5072 , H01L51/5088 , H01L51/5092 , H01L51/5237
摘要： Discussed is a delayed fluorescence compound including a first electron donor moiety of indolo-[3,2,1-j,k]carbazole; a second electron donor moiety selected from indolo-[3,2,1-j,k]carbazole, carbazole, or triphenylamine; and an electron acceptor moiety selected from dibenzothiophene sulfone or diphenyl sulfone, wherein the first and second electron donor moieties are combined to the electron acceptor moiety, and the electron acceptor moiety is combined to a third position or a sixth position of the first electron donor moiety.
摘要翻译：讨论的是延迟荧光化合物，包括吲哚并[3,2,1-j，k]咔唑的第一电子供体部分; 选自吲哚并[3,2,1-j，k]咔唑，咔唑或三苯胺的第二电子供体部分; 和选自二苯并噻吩砜或二苯基砜的电子受体部分，其中第一和第二电子给体部分与电子受体部分结合，并且电子受体部分结合到第一电子给体部分的第三位或第六位。

49. 发明授权

US09273012B2 Facile preparation of 4-substituted quinazolines and related heterocycles 有权
标题翻译：四取代喹唑啉及相关杂环的简便制备
公开(公告)号：US09273012B2
公开(公告)日：2016-03-01
申请号：US13459297
申请日：2012-04-30
申请人： Zerong Daniel Wang
发明人： Zerong Daniel Wang
IPC分类号： C07D239/74 , C07D239/70 , C07D487/06
CPC分类号： C07D239/74 , C07D239/70 , C07D487/06
摘要： A straightforward single step method for the preparation and/or production of substituted quinazolines is disclosed, wherein said quinazolines preferably contain one substituent at position 4, and may contain other functional groups at various positions, such as 5, 6, 7, and/or 8 of quinazolines. In addition, the extension of this new method leads to the formation of different type of heterocyclic aromatic compounds, that include but are not limited to perimidines, anthrapyrimidin-7-ones (also known as anthrapyrimidinones), anthra[1,9:5,10]dipyrimidines (also known as quinazoline[5,4-ef]perimidines) and benzo[e]-pyrimido[4,5,6-gh]pyrimidines.
摘要翻译：公开了用于制备和/或制备取代喹唑啉的简单的单步方法，其中所述喹唑啉优选在第4位包含一个取代基，并且可以在各种位置例如5,6,7和/或其中含有其它官能团。 8个quinazolines。此外，这种新方法的扩展导致形成不同类型的杂环芳族化合物，其包括但不限于季亚胺，蒽并嘧啶-7-酮（也称为蒽吡啶酮），蒽[1,9：5， 10]二嘧啶（也称为喹唑啉[5,4-ef]亚叶酸）和苯并[e] - 嘧啶并[4,5,6-g]嘧啶。

50. 发明申请

US20150045351A1 TRICYCLIC COMPOUND 有权
标题翻译：三聚体化合物
公开(公告)号：US20150045351A1
公开(公告)日：2015-02-12
申请号：US14381347
申请日：2013-03-06
申请人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
发明人： Tomokazu Kusumoto , Shigekazu Sasaki , Hironobu Maezaki
IPC分类号： C07D495/06 , C07D491/06 , C07D487/06
CPC分类号： C07D495/06 , C07D487/06 , C07D491/06
摘要： The present invention provides a compound having a superior serotonin 5-HT2C receptor activating action.The present invention relates to a compound represented by the formula (1) wherein ring A is an aromatic carbocycle optionally having substituent(s) or an aromatic heterocycle optionally having substituent(s), X is —N(R1)—, —O— or the like, when ring A is an aromatic carbocycle optionally having substituent(s), then R1 is a hydrogen atom, an alkyl group optionally having substituent(s), or the like, and when ring A is an aromatic heterocycle optionally having substituent(s), then R1 is a hydrogen atom, an alkyl group optionally having substituent(s), a cycloalkyl group optionally having substituent(s), or the like, is a single bond or a double bond, and n is an integer of 0, 1 or 2, or a salt thereof.
摘要翻译：本发明提供具有优良的5-羟色胺5-HT 2C受体激活作用的化合物。本发明涉及由式（1）表示的化合物，其中环A是任选具有取代基的芳族碳环或任选具有取代基的芳族杂环，X是-N（R 1） - ，-O- 当环A是任选具有取代基的芳族碳环，则R1是氢原子，任选具有取代基的烷基等，当环A是任选具有取代基的芳族杂环时，那么R 1是氢原子，任选具有取代基的烷基，任选具有取代基的环烷基等是单键或双键，n是整数 0,1或2，或其盐。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式